Mental health · Sherman Oaks, CA
Mental health studies in Sherman Oaks, CA
7 recruiting studies have a site in Sherman Oaks.
7 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
2 studies with pay posted
Exact amounts posted by the research company for each study. The button opens that study’s own page.
Pays up to
$1,125
Social Anxiety Study
CenExel · Sherman Oaks, CA
Ages 18–65 · Male/Female
View study & apply (opens in a new tab)Opens CenExel’s page for this exact study
Pays up to
$1,000
Major Depression Trials
CenExel · Sherman Oaks, CA
Ages 18–65 · Male/Female
View study & apply (opens in a new tab)Opens CenExel’s page for this exact study
More recruiting studies (pay not posted)
- RecruitingPhase 2
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
MapLight Therapeutics
- Location
- Sherman Oaks, CA + 41 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Axsome Therapeutics, Inc.
- Location
- Sherman Oaks, CA + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Intra-Cellular Therapies, Inc.
- Location
- Sherman Oaks, CA + 22 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
AbbVie
- Location
- Sherman Oaks, CA + 32 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
AbbVie
- Location
- Sherman Oaks, CA + 32 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Neurocrine Biosciences
- Location
- Sherman Oaks, CA + 20 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder
VistaGen Therapeutics, Inc.
- Location
- Sherman Oaks, CA + 6 other US sites
- Eligibility basics
- Ages 18–65
Who these studies look for
Studies usually require a confirmed diagnosis and stable circumstances, and they monitor safety closely. If you are in crisis, contact a crisis line or emergency services rather than a study.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.